Literature DB >> 10571969

Feasibility of in vivo intravascular ultrasound tissue characterization in the detection of early vascular transplant rejection.

A Jeremias1, M L Kolz, T S Ikonen, J F Gummert, A Oshima, M Hayase, Y Honda, N Komiyama, G J Berry, R E Morris, P G Yock, P J Fitzgerald.   

Abstract

BACKGROUND: Unprocessed ultrasound radiofrequency (RF) signal analysis has been shown to distinguish different tissue structures more reliably than gray-scale interpretation of conventional ultrasound images. METHODS AND
RESULTS: The objective of this study was to test the feasibility of in vivo intravascular ultrasound (IVUS) RF signal analysis in an animal model of allograft rejection. Six cynomolgus monkeys underwent transplantation of 3-cm aortic allograft segments distal to the renal arteries from immunologically mismatched donors. IVUS imaging with a 30-MHz system was performed 84 to 105 days after the operation. RF signals were acquired from cross sections of the recipient and the allograft aortas in real time with a digitizer at 500 MHz with 8-bit resolution. Sixty-five cross sections and 68 regions of interest (31 in host aorta and 37 in allograft) were analyzed in the adventitial layer with a total number of 8568 vectors processed. For each region of interest, a weighted-average attenuation was calculated on the basis of the attenuation and length for each individual vector. Histological examination was performed at every cross section imaged by IVUS. When the gray-scale images of conventional IVUS scored by an independent observer were compared, no distinction between adventitia of the native aorta and allograft was possible. Analysis of the average RF backscatter power also showed no significant difference (70.32+/-3.55 versus 70.72+/-3.38 dB). However, the average attenuation of allografts was significantly lower than that of the host aortas (2.64+/-1.38 versus 4.02+/-1.16 dB/mm, P<0.001). Histology demonstrated a marked adventitial inflammatory response in all allografts, with no inflammation observed in the host aortas.
CONCLUSIONS: In vivo IVUS tissue characterization can be performed during routine imaging. In this model of transplant vasculopathy, RF attenuation measurements were more sensitive than visual or quantitative gray-scale analysis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10571969     DOI: 10.1161/01.cir.100.21.2127

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

1.  Virtual histology by intravascular ultrasound study on degenerative aortocoronary saphenous vein grafts.

Authors:  Man-Hong Jim; William Kong-to Hau; Ryan Lap-Yan Ko; Chung-Wah Siu; Hee-Hwa Ho; Kai-Hang Yiu; Chu-Pak Lau; Wing-Hing Chow
Journal:  Heart Vessels       Date:  2010-05-29       Impact factor: 2.037

Review 2.  Imaging of atherosclerotic plaque using radiofrequency ultrasound signal processing.

Authors:  Stéphane G Carlier; Gary S Mintz; Gregg W Stone
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

Review 3.  What has intravascular ultrasound taught us about plaque biology?

Authors:  S Kinlay
Journal:  Curr Atheroscler Rep       Date:  2001-05       Impact factor: 5.113

4.  The potential of RF backscattered IVUS data and multidetector-row computed tomography images for tissue characterization of human coronary atherosclerotic plaques.

Authors:  Ryuichi Funada; Yuji Oikawa; Junji Yajima; Hajime Kirigaya; Kazuyuki Nagashima; Ken Ogasawara; Shunsuke Matsuno; Toshiro Inaba; Yuya Nakagawa; Michinari Nakamura; Masahiko Kurabayashi; Tadanori Aizawa
Journal:  Int J Cardiovasc Imaging       Date:  2009-03-05       Impact factor: 2.357

5.  Positive Vascular Remodeling in Culprit Coronary Lesion is Associated With Plaque Composition: An Intravascular Ultrasound-Virtual Histology Study.

Authors:  Chung Seop Lee; Young Hoon Seo; Dong Ju Yang; Ki Hong Kim; Hyun Woong Park; Hyung Bin Yuk; Moo-Sik Lee; Wan-Ho Kim; Taek-Geun Kwon; Jang-Ho Bae
Journal:  Korean Circ J       Date:  2012-11-28       Impact factor: 3.243

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.